» Articles » PMID: 10188992

Effects of Vasopressin on the Sympathetic Contraction of Rabbit Ear Artery During Cooling

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1999 Apr 3
PMID 10188992
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In order to analyse the effects of arginine-vasopressin on the vascular contraction to sympathetic nerve stimulation during cooling, the isometric response of isolated, 2-mm segments of the rabbit central ear (cutaneous) artery to electrical field stimulation (1-8 Hz) was recorded at 37 and 30 degrees C. Electrical stimulation (37 degrees C) produced frequency-dependent arterial contraction, which was reduced at 30 degrees C and potentiated by vasopressin (10 pM, 100 pM and 1 nM). This potentiation was greater at 30 than at 37 degrees C and was abolished at both temperatures by the antagonist of vasopressin V1 receptors d(CH2)5 Tyr(Me)AVP (100 nM). Desmopressin (1 microM) did not affect the response to electrical stimulation. At 37 degrees C, the vasopressin-induced potentiation was abolished by the purinoceptor antagonist PPADS (30 microM), increased by phentolamine (1 microM) or prazosin (1 microM) and not modified by yohimbine (1 microM), whilst at 30 degrees C, the potentiation was reduced by phentolamine, yohimbine or PPADS, and was not modified by prazosin. The Ca2+-channel blockers, verapamil (10 microM) and NiCl2 (1 mM), abolished the potentiating effects of vasopressin at 37 degrees C whilst verapamil reduced and NiCl2 abolished this potentiation at 30 degrees C. The inhibitor of nitric oxide synthesis, L-NOARG (100 microM), or endothelium removal did not modify the potentiation by vasopressin at 37 and 30 degrees C. Vasopressin also increased the arterial contraction to the alpha2-adrenoceptor agonist BHT-920 (10 microM) and to ATP (2 mM) at 30 and 37 degrees C, but it did not modify the contraction to noradrenaline (1 microM) at either temperature. These results suggest that in cutaneous (ear) arteries, vasopressin potentiaties sympathetic vasoconstriction to a greater extent at 30 than at 37 degrees C by activating vasopressin V1 receptors and Ca2+ channels at both temperatures. At 37 degrees C, the potentiation appears related to activation of the purinoceptor component and, at 30 degrees C, to activation of both purinoceptor and alpha2-adrenoceptor components of the sympathetic response.

Citing Articles

Efficacy of cooling therapy and α-lipoic acid derivative against chemotherapy-induced alopecia in an animal model.

Aiba T, Kono Y, Etoh T, Kawano Y, Oshima Y, Inomata M Cancer Sci. 2022; 114(3):1007-1014.

PMID: 36337052 PMC: 9986063. DOI: 10.1111/cas.15639.


Role of alpha2C-adrenoceptors in the reduction of skin blood flow induced by local cooling in mice.

Honda M, Suzuki M, Nakayama K, Ishikawa T Br J Pharmacol. 2007; 152(1):91-100.

PMID: 17618305 PMC: 1978266. DOI: 10.1038/sj.bjp.0707380.

References
1.
BARTELSTONE H, NASMYTH P, TELFORD J . The significance of adenosine cyclic 3',5'-monophosphate for the contraction of smooth muscle. J Physiol. 1967; 188(2):159-76. PMC: 1396005. DOI: 10.1113/jphysiol.1967.sp008131. View

2.
Padilla J, Garcia-Villalon A, Fernandez N, Monge L, Gomez B, Dieguez G . Effects of hyperthermia on contraction and dilatation of rabbit femoral arteries. J Appl Physiol (1985). 1998; 85(6):2205-12. DOI: 10.1152/jappl.1998.85.6.2205. View

3.
Patton J, Wallace W . Responses of isolated rabbit ear arteries to intra- and extraluminal L- and D-noradrenaline, L-adrenaline and histamine in the temperature range 37-3 degrees C. Ir J Med Sci. 1978; 147(9):313-7. DOI: 10.1007/BF02939425. View

4.
Roberts M, Zygmunt A . Reflex and local thermal control of rabbit ear blood flow. Am J Physiol. 1984; 246(6 Pt 2):R979-84. DOI: 10.1152/ajpregu.1984.246.6.R979. View

5.
Kennedy C, Saville V, Burnstock G . The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol. 1986; 122(3):291-300. DOI: 10.1016/0014-2999(86)90409-7. View